Find out why this 7% yielding blue-chip is not just a potentially very strong buy now, but also one of the best investments retirees can make in this overvalued and dangerous market.
Continue Reading ...
This 8.6% yielding dividend king just re-affirmed the safety of its dividend, credit rating agencies agree, and from the best valuation in 12 years, analysts believe it could generate 30% CAGR total returns over the coming years.
Continue Reading ...
Pfizer’s latest mega-deal might lead to a dividend cut, but also a much more profitable and ultimately faster-growing company. Here are three things investors need to know about this high-yield defensive blue-chip.
Continue Reading ...
If you want a fast-growing recession-resistant high-yield blue chip run by brilliant and conservative management, that you can trust to not cut its dividend in this recession look no further than this often overlooked utility. One that is likely to achieve management’s long-term goals of delivering 12% to 15% CAGR long-term total returns that significantly outperforms the market as it has over the last 12 years.
Continue Reading ...If you are worried about the next recession then these three high-yield blue chips are perfect for you. Each one provides: generous, safe, and steadily rising income, along with ultra low volatility thanks to a recession proof business model.
Continue Reading ...
